Literature DB >> 34556886

OCT2 pre-positioning facilitates cell fate transition and chromatin architecture changes in humoral immunity.

Ashley S Doane1,2, Chi-Shuen Chu3, Dafne Campigli Di Giammartino4, Martín A Rivas4, Johannes C Hellmuth4, Yanwen Jiang1,4, Nevin Yusufova4, Alicia Alonso4, Robert G Roeder3, Effie Apostolou4, Ari M Melnick5, Olivier Elemento6.   

Abstract

During the germinal center (GC) reaction, B cells undergo profound transcriptional, epigenetic and genomic architectural changes. How such changes are established remains unknown. Mapping chromatin accessibility during the humoral immune response, we show that OCT2 was the dominant transcription factor linked to differential accessibility of GC regulatory elements. Silent chromatin regions destined to become GC-specific super-enhancers (SEs) contained pre-positioned OCT2-binding sites in naive B cells (NBs). These preloaded SE 'seeds' featured spatial clustering of regulatory elements enriched in OCT2 DNA-binding motifs that became heavily loaded with OCT2 and its GC-specific coactivator OCAB in GC B cells (GCBs). SEs with high abundance of pre-positioned OCT2 binding preferentially formed long-range chromatin contacts in GCs, to support expression of GC-specifying factors. Gain in accessibility and architectural interactivity of these regions were dependent on recruitment of OCAB. Pre-positioning key regulators at SEs may represent a broadly used strategy for facilitating rapid cell fate transitions.
© 2021. The Author(s), under exclusive licence to Springer Nature America, Inc.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34556886     DOI: 10.1038/s41590-021-01025-w

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  60 in total

1.  Multi-tiered Reorganization of the Genome during B Cell Affinity Maturation Anchored by a Germinal Center-Specific Locus Control Region.

Authors:  Karen L Bunting; T David Soong; Rajat Singh; Yanwen Jiang; Wendy Béguelin; David W Poloway; Brandon L Swed; Katerina Hatzi; William Reisacher; Matt Teater; Olivier Elemento; Ari M Melnick
Journal:  Immunity       Date:  2016-09-13       Impact factor: 31.745

2.  BCL6 Evolved to Enable Stress Tolerance in Vertebrates and Is Broadly Required by Cancer Cells to Adapt to Stress.

Authors:  Tharu M Fernando; Rossella Marullo; Benet Pera Gresely; Jude M Phillip; Shao Ning Yang; Geoffrey Lundell-Smith; Ingrid Torregroza; Haelee Ahn; Todd Evans; Balázs Győrffy; Gilbert G Privé; Masayuki Hirano; Ari M Melnick; Leandro Cerchietti
Journal:  Cancer Discov       Date:  2019-02-18       Impact factor: 39.397

3.  CREBBP Inactivation Promotes the Development of HDAC3-Dependent Lymphomas.

Authors:  Yanwen Jiang; Ana Ortega-Molina; Huimin Geng; Hsia-Yuan Ying; Katerina Hatzi; Sara Parsa; Dylan McNally; Ling Wang; Ashley S Doane; Xabier Agirre; Matt Teater; Cem Meydan; Zhuoning Li; David Poloway; Shenqiu Wang; Daisuke Ennishi; David W Scott; Kristy R Stengel; Janice E Kranz; Edward Holson; Sneh Sharma; James W Young; Chi-Shuen Chu; Robert G Roeder; Rita Shaknovich; Scott W Hiebert; Randy D Gascoyne; Wayne Tam; Olivier Elemento; Hans-Guido Wendel; Ari M Melnick
Journal:  Cancer Discov       Date:  2016-10-12       Impact factor: 39.397

4.  The CREBBP Acetyltransferase Is a Haploinsufficient Tumor Suppressor in B-cell Lymphoma.

Authors:  Jiyuan Zhang; Sofija Vlasevska; Victoria A Wells; Sarah Nataraj; Antony B Holmes; Romain Duval; Stefanie N Meyer; Tongwei Mo; Katia Basso; Paul K Brindle; Shafinaz Hussein; Riccardo Dalla-Favera; Laura Pasqualucci
Journal:  Cancer Discov       Date:  2017-01-09       Impact factor: 39.397

Review 5.  Germinal Center B Cell Dynamics.

Authors:  Luka Mesin; Jonatan Ersching; Gabriel D Victora
Journal:  Immunity       Date:  2016-09-20       Impact factor: 31.745

6.  A hybrid mechanism of action for BCL6 in B cells defined by formation of functionally distinct complexes at enhancers and promoters.

Authors:  Katerina Hatzi; Yanwen Jiang; Chuanxin Huang; Francine Garrett-Bakelman; Micah D Gearhart; Eugenia G Giannopoulou; Paul Zumbo; Kevin Kirouac; Srividya Bhaskara; Jose M Polo; Matthias Kormaksson; Alexander D MacKerell; Fengtian Xue; Christopher E Mason; Scott W Hiebert; Gilbert G Prive; Leandro Cerchietti; Vivian J Bardwell; Olivier Elemento; Ari Melnick
Journal:  Cell Rep       Date:  2013-08-01       Impact factor: 9.423

7.  Histone demethylase LSD1 is required for germinal center formation and BCL6-driven lymphomagenesis.

Authors:  Katerina Hatzi; Huimin Geng; Ashley S Doane; Cem Meydan; Reed LaRiviere; Mariano Cardenas; Cihangir Duy; Hao Shen; Maria Nieves Calvo Vidal; Timour Baslan; Helai P Mohammad; Ryan G Kruger; Rita Shaknovich; Ann M Haberman; Giorgio Inghirami; Scott W Lowe; Ari M Melnick
Journal:  Nat Immunol       Date:  2018-12-10       Impact factor: 25.606

Review 8.  The Transcriptional Regulation of Germinal Center Formation.

Authors:  Shuang Song; Patrick D Matthias
Journal:  Front Immunol       Date:  2018-09-05       Impact factor: 7.561

Review 9.  Germinal center-derived lymphomas: The darkest side of humoral immunity.

Authors:  Coraline Mlynarczyk; Lorena Fontán; Ari Melnick
Journal:  Immunol Rev       Date:  2019-03       Impact factor: 12.988

10.  Long non-coding RNAs discriminate the stages and gene regulatory states of human humoral immune response.

Authors:  Xabier Agirre; Cem Meydan; Yanwen Jiang; Leire Garate; Ashley S Doane; Zhuoning Li; Akanksha Verma; Bruno Paiva; José I Martín-Subero; Olivier Elemento; Christopher E Mason; Felipe Prosper; Ari Melnick
Journal:  Nat Commun       Date:  2019-02-18       Impact factor: 14.919

View more
  2 in total

Review 1.  Three-dimensional genome organization in immune cell fate and function.

Authors:  Sergi Cuartero; Grégoire Stik; Ralph Stadhouders
Journal:  Nat Rev Immunol       Date:  2022-09-20       Impact factor: 108.555

Review 2.  3D chromosomal architecture in germinal center B cells and its alterations in lymphomagenesis.

Authors:  Antonin Papin; Ethel Cesarman; Ari Melnick
Journal:  Curr Opin Genet Dev       Date:  2022-05-09       Impact factor: 4.665

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.